XDH and heart failure: Another meta-analysis involving 3,803,509 participants indicated that xanthine oxidase inhibitors were not associated with a reduction in cardiovascular events compared to placebo, and febuxostat may reduce the risk of heart failure compared to xanthine oxidase inhibitors [88].